Automatic Segmentation Ultrasound-based Radiomics Technology in Diabetic Kidney Disease

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Completed
CT.gov ID
NCT05025540
Collaborator
(none)
499
3
6
166.3
27.7

Study Details

Study Description

Brief Summary

Diabetic kidney disease is a common complication of diabetes and the main cause of end-stage renal disease. In this study, the investigator plan to enroll nearly 500 participant with/without DKD and to develop an automatic segmentation ultrasound based radiomics technology to differentiating participant with a non-invasive and an available way.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: ultrasonic imaging

Detailed Description

Ultrasound examination is a convenient, cheap and non-invasive method for kidney examination. However, the ability of conventional ultrasound to distinguish diabetic kidney disease from normal kidney is limited, and it is difficult to accurately distinguish between diabetic kidney disease and normal kidney only with the naked eye. In recent years, computer science has developed rapidly and artificial intelligence has been developing continuously. Much progress has been made in applying artificial intelligence in data analysis. Machine learning is a direction of generalized artificial intelligence, its main characteristic is to make the machine autonomous prediction and create algorithm, so as to achieve autonomous learning. kidney disease and deep learning are two different approaches in the field of machine learning. In this study, image omics and deep learning were used to analyze the images. Image omics extracts traditional image features, including shape, gray scale, texture, etc., and uses machine learning (pattern recognition) models to classify and predict, such as support vector machine, random forest, XGBoost, etc. Deep learning directly uses the convolutional network CNN to extract features, and completes classification and prediction in combination with the full connection layer, etc.

This study aims to explore the detection of diabetic kidney disease and its pathological degree based on automatic segmentation ultraound-based radiomics technology, mining of internal information of ultrasound images, and form a set of non-invasive monitoring of diabetic kidney disease complications development system, especially in primary medical institutions, has a broad clinical application prospect.

Study Design

Study Type:
Observational
Actual Enrollment :
499 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Noninvasive Detection of Diabetic Kidney Disease Based on Automatic Segmentation Ultrasound-based Radiomics Technology
Actual Study Start Date :
Jun 1, 2021
Actual Primary Completion Date :
Dec 1, 2021
Actual Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental group

Experimental group1:DKD patients with Type 2 diabetes patients with DKD Experimental group2:High level DKD patients with diabetic kidney disease Stage III and IV.

Diagnostic Test: ultrasonic imaging
Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.

Control group

Control1:T2DM patients with Type 2 diabetes Control2:Low level DKD patients with diabetic kidney disease Stage I and II.

Diagnostic Test: ultrasonic imaging
Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.

Outcome Measures

Primary Outcome Measures

  1. AUC [6 months]

    The area under curve (AUC) of radiomics model for differentiating DKD and T2DM or high level and low level DKD patients

Secondary Outcome Measures

  1. Miou [6 months]

    The mean intersection over union (Miou) of DL-based auto-segmentation in different medical centers

  2. mPA [6 months]

    The mean pixel accuracy (mPA) of DL-based auto-segmentation in different medical centers

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with clinical diagnosis of T2DM and DKD were enrolled.

  • patients with clear B mode ultrasound imaging in both side of kidney (left and right).

  • No missing value in the vital clinical data such as eGFR and UACR.

Exclusion Criteria:
  • Patients with large kidney space occupying disease such as kidney renal cyst and tumor were excluded.

  • Ultrasound images with severe shadow or incomplete kidney border were excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The People's Hospital of Yingshang Fuyang Anhui China 236200
2 Tianjin Third Central Hospital Tianjin Tianjin China 300000
3 Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang China 310000

Sponsors and Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

Investigators

  • Study Chair: Pintong Huang, Department of Ultrasound, The Second Affiliated Hospital of Zhejiang University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier:
NCT05025540
Other Study ID Numbers:
  • 2021-0465
First Posted:
Aug 27, 2021
Last Update Posted:
Feb 16, 2022
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Second Affiliated Hospital, School of Medicine, Zhejiang University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2022